Skopos Labs, Inc. Harrow Health, Inc. Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 8 shares of HROW stock, worth $296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 8
-0.0%
Holding current value
$296
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HROW
# of Institutions
186Shares Held
21.7MCall Options Held
390KPut Options Held
413K-
Opaleye Management Inc. Boston, MA3.91MShares$145 Million28.52% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$79.7 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.95MShares$72.2 Million6.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$69.3 Million0.0% of portfolio
-
Braidwell LP Stamford, CT872KShares$32.4 Million1.63% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...